Marker linked with most deadly brain tumours:
This article was originally published in Clinica
Executive Summary
A US research team has identified what could be a marker for some of the most prevalent and difficult-to-manage forms of brain tumour - human high-grade gliomas. In a study of tumours from 23 patients with glioblastoma multiforme, the team found that more than 90% of patients possessed a receptor for an immune regulatory factor, interleukin 13. The study, led by Dr Waldemar Debinski of the Penn State's College of Medicine in Hershey, Pennsylvania, is published in the May issue of Clinical Cancer Research.